Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000696	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2021-01-05	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Certificate Issued	2021-03-17	view
JYSB2000695	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000694	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000693	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000692	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000691	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000690	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000689	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000688	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2021-01-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2022-01-20	view
JYSB2000662	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-12-28	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-12-24	view
JYSB2000654	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-12-25	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2021-01-06	view
JYSB2000653	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-12-25	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2021-01-06	view
JYSB2000601	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-12-07	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-12-17	view
JYSB2000563	贝伐珠单抗注射液	bevacizumab	Injection	Biological Products	Supplementary Application	2020-11-07	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-11-20	view
JYSB2000530	贝伐珠单抗注射液	bevacizumab	Injection	Biological Products	Supplementary Application	2020-10-26	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-11-09	view
JYSB2000426	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-09-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-11	view
JYSB2000425	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-09-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-11	view
JYSB2000414	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2020-08-21	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-02	view
JYSB2000413	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2020-08-21	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-02	view
JYSB2000412	艾美赛珠单抗注射液	emicizumab	Injection	Biological Products	Supplementary Application	2020-08-21	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-02	view